Skip to main content
Bharat Rasayan Limited logo

Bharat Rasayan Limited — Investor Relations & Filings

Ticker · BHARATRAS ISIN · INE838B01021 LEI · 335800NXICUEZQ62XR71 BSE.NS Manufacturing
Open in API
Filings indexed 857 across all filing types
Latest filing 2026-05-26 Regulatory Filings
Country IN India
Listing BSE.NS BHARATRAS

About Bharat Rasayan Limited

https://www.bharatgroup.co.in/

Bharat Rasayan Limited specializes in the manufacturing of technical grade pesticides, formulations, and intermediates. The company’s product portfolio encompasses a broad range of insecticides, herbicides, and fungicides designed for effective crop protection. Operating advanced production facilities in Rohtak and Dahej, the organization maintains a strong focus on research and development to drive process innovation and product quality. Its business model emphasizes backward integration, ensuring a consistent supply of raw materials and cost-efficiency. Bharat Rasayan serves a diverse global clientele, providing high-quality chemical solutions to the agricultural sector. The company is recognized for its technical expertise, adherence to international safety standards, and commitment to sustainable manufacturing practices within the agrochemical space.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 88% confidence The document is a formal NEAPS e-filing under SEBI LODR regulation 30/33/43 notifying the stock exchanges of the Board meeting outcomes. It covers approval of audited annual financial results (with auditor’s report attached), dividend recommendation, multiple director changes (resignation, appointment, tenure completion), internal auditor appointment, and related disclosures. It does not itself constitute the full Annual Report (10-K), nor is it solely an earnings press release (ER), proxy materials (PSI), or a standalone audit report (AR). Instead, it is a regulatory compliance announcement covering various board and financial matters – a general regulatory filing. Hence it falls under the fallback Regulatory Filings category (RNS).
2026-05-26 English
Outcome of Board Meeting
Regulatory Filings Classification · 90% confidence The document is a letter from Bharat Rasayan Limited to the stock exchanges under SEBI (LODR) Regulations announcing the outcome of the Board meeting held on May 26, 2026. It lists the approval of audited annual financial results (with attachments referenced rather than included), recommendation of a final dividend, and multiple board/management changes (resignations and appointments), plus the appointment of an internal auditor. This is a regulatory disclosure of Board decisions and compliance, not the full annual report or interim report itself, nor a standalone earnings release. It is therefore best classified under Regulatory Filings (RNS).
2026-05-26 English
Outcome of Board Meeting
Regulatory Filings Classification · 82% confidence The document is a SEBI Listing Regulations compliance filing addressed to the National Stock Exchange and the Bombay Stock Exchange, detailing the outcome of a Board Meeting held on 26 May 2026. It includes approval of standalone and consolidated audited financial results for the fourth quarter and full year ended 31 March 2026 (per Reg. 33), declaration under Reg. 33, recommendation of a final dividend, and multiple board changes (resignation of a whole‐time director, appointment of an additional director, completion of an independent director’s tenure, and appointment of an internal auditor under Reg. 30). It is not the full Annual Report (10‐K), not merely a Proxy Statement, not a standalone Audit Report (AR), not just a Management Discussion (MDA), and not an Earnings Release (ER) in the sense of key highlights only. It is a combined compliance and regulatory announcement to the exchanges covering multiple disclosures under SEBI (LODR) Regulations, thus fitting the “Regulatory Filings” (RNS) category as a general regulatory announcement and compliance document.
2026-05-26 English
Cessation
Regulatory Filings Classification · 85% confidence The document is a letter to the stock exchanges under SEBI (LODR) Regulations 30, 33 and 43 announcing the outcome of the Board meeting held on 26 May 2026. It describes the approval of the audited standalone and consolidated financial results for the quarter and year ended 31 March 2026 (with auditor’s reports attached) and corporate actions such as director appointments/resignations, dividend recommendation, and internal auditor appointment. This is a regulatory announcement/disclosure rather than the full Annual Report (10-K), standalone Audit Report (AR), or a simple earnings highlights release (ER). It does not represent a proxy statement, a detailed investor presentation, an interest rate notice, or any other narrowly defined category, so it falls into the general “Regulatory Filings” (RNS) fallback.
2026-05-26 English
Resignation
Regulatory Filings Classification · 90% confidence The document is a regulatory submission to the Indian stock exchanges under SEBI LODR rules covering multiple agenda items: the Board’s approval of the audited annual financial results (with auditor’s reports attached), recommendation of a final dividend, and several Board changes (resignations, appointments, internal auditor). It is not the full Annual Report itself (10-K) nor purely an earnings press release, and the attachments (actual results and audit report) are referenced but not contained. It also covers management/board appointments but is broader than a pure MANG filing. Therefore it best fits the fallback Regulatory Filings category (RNS).
2026-05-26 English
Appointment
Regulatory Filings Classification · 83% confidence The document is a formal disclosure to stock exchanges under SEBI LODR (Regulations 30, 33, 43 etc.), summarizing the outcome of a Board meeting. It provides notice of: (a) approval of standalone and consolidated audited financial results for the fourth quarter and financial year ended March 31, 2026 (with auditor’s reports and declarations attached), (b) recommendation of a final dividend, and (c) several board changes (resignation, new appointment, completion of tenure, appointment of internal auditor). It is not the company’s full annual report (10-K), nor a simple earnings release (ER) or pure board/management change notice (MANG), but rather a composite regulatory compliance filing disclosing financial results and corporate actions. This type of catch-all exchange submission falls under “Regulatory Filings” (RNS).
2026-05-26 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.